NP+PA Perspectives in Dermatology: September 2023

Click the cover to access the full digital edition of NP+PA Perspectives in Dermatology, September 2023

J Clin Aesthet Dermatol. 2023;16(9 Suppl 3)

NP+PA Perspectives in Dermatology: September 2023

Life and Career Coaching for NPs and PAs– The Secret to Preventing Clinical Burnout: Start a Side Hustle!
by Kasey D’Amato PA-C, MPAP; Katie Plessinger, PA-C; and Danielle Spatholt, PA-C

Dermatological Conditions in Skin of Color– Clinical Considerations When Treating Acne Vulgaris in Skin of Color
by Archana M. Sangha, MMS, PA-C

Potential Effects, Diagnosis, and Management of De Quervain Tenosynovitis in the Aesthetics Community: A Brief Review, Case Example, and Illustrative Exercises
by Michele Rutkowski, APRN, FNP-C, and Kristy Rutkowski, OTR/L

A Deeper Dive into Dermatopathology—An Interview with Dr. Maria Robinson
by Margaret A. Bobonich, DNP, FNP-C, DCNP, FAANP

Pearls from the Scope: What Your Dermatopathologist Wants You to Know
by Maria R. Robinson, MD, MBA, FAAD

Management of Advanced Invasive Melanoma: New Strategies
by Alessia Villani, Massimiliano Scalvenzi, Giuseppe Micali, Francesco Lacarrubba, Luigi Fornaro, Fabrizio Martora, Luca Potestio

Share:

Recent Articles:

Hadas Skupsky, MD, FAAD: Pigmented Lesion Management for the Dermatologist
Letters to the Editor: May 2025
Tralokinumab as a Therapeutic Alternative for Dupilumab-associated Arthralgia in Atopic Dermatitis: A Multi-center Case Series
The Correlation between Hidradenitis Suppurativa and Irritable Bowel Diseases: A Systematic Review
A Clinician’s Guide to Dupilumab-related Ocular Surface Disease
A Review of Neoadjuvant PD-1 Inhibitors in the Setting of Cutaneous Malignancies
The Treatment of Pembrolizumab-induced Pruritus with Topical Roflumilast Cream 0.3% Once Daily
Ferulic Acid Use for Skin Applications: A Systematic Review
Safety Evaluation of Topical Products Containing Live Cultures and Ferment of Cutibacterium Acnes Subspecies Defendens Strain XYCM42 in Individuals Predisposed to Acne Vulgaris
Interpreting Safety Analyses in Psoriasis Clinical Trials
1 2 3 164

Categories:

Recent Articles:

Michael Cameron, MD, FAAD, and Christopher Bunick, MD, PhD: The Future of Personalized Atopic Dermatitis Treatments to Predict and Avoid Adverse Events
James Del Rosso, DO, and Christopher Bunick, MD: Tralokinumab as a Therapeutic Alternative for Dupilumab-associated Arthralgia in Atopic Dermatitis—A Multi-center Case Series
Naiem Issa, MD, PhD, and Christopher Bunick, MD, PhD: Mechanisms of Dupilumab-associated Arthralgia in Patients with Atopic Dermatitis
Hadas Skupsky, MD, FAAD: Pigmented Lesion Management for the Dermatologist
Jennifer Silva, APRN-DNP: Safety Considerations for Treating Patients with Vitiligo
Letters to the Editor: May 2025
Tralokinumab as a Therapeutic Alternative for Dupilumab-associated Arthralgia in Atopic Dermatitis: A Multi-center Case Series
The Correlation between Hidradenitis Suppurativa and Irritable Bowel Diseases: A Systematic Review
A Clinician’s Guide to Dupilumab-related Ocular Surface Disease
A Review of Neoadjuvant PD-1 Inhibitors in the Setting of Cutaneous Malignancies
1 2 3 202

Tags: